Literature DB >> 31001641

No Correlation Between Nasopharyngeal Human Bocavirus 1 Genome Load and mRNA Detection or Serology in Adeno-/Tonsillectomy Patients.

Lotta E Ivaska1, Andreas Christensen2,3, Matti Waris4, Tuomo Puhakka1, Tytti Vuorinen4, Tobias Allander5, Maria Söderlund-Venermo6, Tuomas Jartti7.   

Abstract

Human bocavirus 1 (HBoV1) can persist in nasopharynx and tonsils. Using HBoV1 serology, reverse-transcription polymerase chain reaction (PCR) for detecting messenger RNA (mRNA) and quantitative PCR for HBoV1 genome load count, we studied to what extent the HBoV1 DNA loads in nasopharynx correlate with acute infection markers. Tonsillar tissue, nasopharyngeal aspirate, and serum were obtained from 188 elective adeno-/tonsillectomy patients. Relatively high loads of HBoV1 DNA were detected in the nasopharynx of 14 (7%) primarily asymptomatic subjects with negative mRNA and/or serodiagnostic results. Quantitative HBoV1 DNA PCR may have lower specificity than HBoV1 mRNA detection for diagnosing symptomatic infection.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  bocavirus; detection; diagnosis; nasopharynx; parvovirus; serology; tonsil

Mesh:

Substances:

Year:  2019        PMID: 31001641     DOI: 10.1093/infdis/jiz166

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  2 in total

1.  Prevalence, Cell Tropism, and Clinical Impact of Human Parvovirus Persistence in Adenomatous, Cancerous, Inflamed, and Healthy Intestinal Mucosa.

Authors:  Man Xu; Katarzyna Leskinen; Tommaso Gritti; Valerija Groma; Johanna Arola; Anna Lepistö; Taina Sipponen; Päivi Saavalainen; Maria Söderlund-Venermo
Journal:  Front Microbiol       Date:  2022-05-24       Impact factor: 6.064

2.  Herpesvirus infections in adenoids in patients with chronic adenotonsillar disease.

Authors:  Lotta E Ivaska; Antti Silvoniemi; Emilia Mikola; Tuomo Puhakka; Matti Waris; Tytti Vuorinen; Tuomas Jartti
Journal:  J Med Virol       Date:  2022-05-11       Impact factor: 20.693

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.